Life science tech VC firm backs $420m SPAC

Anzu Special Acquisition Corp I has priced its IPO at $420 million as shares began trading on the Nasdaq on March 2.

Sponsored by Anzu Partners, a . . .

Continue Reading With a Free Trial

Unlock this article instantly, along with the rest of our premium content, newsletters and mandate charts.

Already a subscriber? Log in.